Novo Nordisk today announced headline
results from the final phase 3a trials for faster-acting insulin aspart,
onset^® 1 and onset^® 2. The trials investigated the efficacy and safety of
faster-acting insulin aspart compared with NovoRapid^®...
Bristol-Myers Squibb (BMS) said today it agreed to license from Novo Nordisk a research program focused on modulating the innate immune system as a therapy for autoimmune diseases. The price was not disclosed.
The deal fits both BMS’ focus...
Pinnacle Foods Inc. (NYSE: PF) shares reached a new 52-week high of $40.42. Pinnacle Foods' PEG ratio is 1.82.
Novo Nordisk A/S (NYSE: NVO) shares rose 2.63% to touch a new 52-week high of $49.47. Novo Nordisk's trailing-twelve-month ROE is...
It took the collapse of Banco Espírito Santo, rather than the eurozone crisis, to redraw the map of Portuguese banking. Will the revised landscape show Iberian consolidation, or a new Chinese foothold on the continent?
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.
You may also be interested in articles related to Novo Nordisk A/S (NVO):